Healthcare & Life Sciences

Obsidian Therapeutics

Obsidian Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.

activeseries-c-plus
series-c-plus
Stage
2017
Founded
2
Investors

About Obsidian Therapeutics

Based in the United States, Obsidian Therapeutics is a startup founded in 2017. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Obsidian Therapeutics is a biotechnology company focused on developing novel cell therapies using synthetic biology to improve immune system regulation.

Explore Obsidian Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States